Admassu Abebe,Kyle Martin,Jatin M. Patel,Divyakant Desai,Peter Timmins
申请号：
US15450918
公开号：
US20170333353A1
申请日:
2017.03.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
